January 30, 2024

BioSkryb Genomics to Highlight Power of Next Generation Single-Cell Technology at AGBT 2024

BioSkryb to introduce new products and novel applications of industry-leading portfolio that advance the single-cell multiomics field through simultaneous interrogation of DNA, RNA, and targeted proteins from each cell

DURHAM, N.C. – January 30, 2023 - BioSkryb Genomics, a company transforming singl…

November 28, 2023

BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer

Ram Laxman brings executive leadership experience from 10x Genomics, Illumina, and Pacific Biosciences to expand BioSkryb’s international footprint

DURHAM, N.C. – November 29, 2023 - BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of th…

October 30, 2023

BioSkryb Genomics to Present New Single-Cell Multiomic Data at ASHG 2023

BioSkryb will participate in two CoLab Sessions on single-cell whole genome sequencing and four poster presentations with new pancreatic and breast cancer data

DURHAM, N.C. – October 30, 2023 - BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic vie…

September 13, 2023

BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization

As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products

DURHAM, N.C. – September 13, 2023 - BioSkryb Genomics, a company transforming single-cell analysis by e…

August 30, 2023

BioSkryb Genomics Partners with Research Instruments Pte Ltd to Bring Industry Leading Single-Cell Technologies to Singapore and Southeast Asia

Strategic distribution agreement with Research Instruments expands access to BioSkryb’s best-in-class single-cell multiomics portfolio throughout Southeast Asia

DURHAM, N.C. – August 30, 2023 - BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic…

August 17, 2023

Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies

U.S. issued patent expands BioSkryb’s IP portfolio to four granted patents in key geographic markets worldwide

DURHAM, N.C. – August 17, 2023 - BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to…

August 2, 2023

BioSkryb Genomics to Bring High-Throughput Automation to Single-Cell Genomics

The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy

DURHAM, N.C. – August 3, 2023 - BioSkryb Genomics, a pioneer in comprehensive single…

July 18, 2023

BIOKÉ and BioSkryb Genomics announce a distribution agreement for the Benelux and Nordic countries

LEIDEN July 18, 2023 - BIOKÉ, a leading distributor of life science technologies throughout Europe, has partnered with BioSkryb Genomics (BioSkryb), a pioneer in comprehensive single-cell multiomic research solutions, to distribute Primary Template-directed Amplification (PTA) technology acr…

April 12, 2023

BioSkryb Genomics Unveils New Research Findings Related to Breast Cancer Tumor Evolution

BioSkryb will present new findings at AACR 2023 that challenge the status quo in the single-cell analysis market

DURHAM, N.C. – April 12, 2023 - BioSkryb Genomics, a pioneer in comprehensive single-cell multiomic research solutions, today announced that it will share new, groundbreaking research rel…

February 7, 2023

BioSkryb Announces Commercial Launch of ResolveOME System and BaseJumper Bioinformatics Platform

Comprehensive system that enables unmatched single cell multiomic analysis is now widely available following the completion of a successful Early Access Program

DURHAM, N.C. – February 7, 2023 - BioSkryb Genomics, a pioneer in comprehensive single cell multiomic research solutions, today announced t…